Form D · Pharmaceuticals
Stromedix Inc
Cambridge, MA · CIK 0001393680
Offering snapshot reported Jan 25, 2011 · SEC filing
- Reported sold
- $2M Offering amount: $15.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 24, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2011 | Initial | $2,000,000 | No comparison | 9 | SEC filing |
| Apr 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 31, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 16, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-154307
Source: Form D, filed Jan 25, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Barrett | Director |
| Michael Gilman | Director, Executive |
| Ronald Hunt | Director |
| Stephen Kraus | Director |
| Daniel Lynch | Director, Executive |
| Brad Maroni | Executive |
| Sheila Violette | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One Canal Park, Suite 1120
Cambridge, MA, 02141
Cambridge, MA, 02141